Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Stratification of inflammatory bowel disease outpatients by disease activity and risk of complications to guide out-of-hospital monitoring: a patient-centred quality improvement project.

Fofaria RK, Barber S, Adeleke Y, Woodcock T, Kamperidis N, Mohamed A, Misra R, Shah A, Bailey-Fee S, Bluston H, Robinson D, Tyrrell T, Arebi N.

BMJ Open Qual. 2019 Aug 1;8(3):e000546. doi: 10.1136/bmjoq-2018-000546. eCollection 2019.

2.

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.

Kopylov U, Verstockt B, Biedermann L, Sebastian S, Pugliese D, Sonnenberg E, Steinhagen P, Arebi N, Ron Y, Kucharzik T, Roblin X, Ungar B, Shitrit AB, Ardizzone S, Molander P, Coletta M, Peyrin-Biroulet L, Bossuyt P, Avni-Biron I, Tsoukali E, Allocca M, Katsanos K, Raine T, Sipponen T, Fiorino G, Ben-Horin S, Eliakim R, Armuzzi A, Siegmund B, Baumgart DC, Kamperidis N, Maharshak N, Maaser C, Mantzaris G, Yanai H, Christodoulou DK, Dotan I, Ferrante M.

Inflamm Bowel Dis. 2018 Oct 12;24(11):2442-2451. doi: 10.1093/ibd/izy155.

PMID:
29788318
3.

The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery.

Kamperidis N, Faiz O, Arebi N.

Ann Surg. 2017 Dec;266(6):e61-e62. doi: 10.1097/SLA.0000000000001502. No abstract available.

PMID:
29136975
4.

Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease.

Goodhand JR, Kamperidis N, Sirwan B, Macken L, Tshuma N, Koodun Y, Chowdhury FA, Croft NM, Direkze N, Langmead L, Irving PM, Rampton DS, Lindsay JO.

Aliment Pharmacol Ther. 2013 Nov;38(9):1097-108. doi: 10.1111/apt.12476. Epub 2013 Sep 15.

5.

The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descent.

Goodhand JR, Kamperidis N, Joshi NM, Wahed M, Koodun Y, Cantor EJ, Croft NM, Langmead FL, Lindsay JO, Rampton DS.

Aliment Pharmacol Ther. 2012 Apr;35(8):929-40. doi: 10.1111/j.1365-2036.2012.05043.x. Epub 2012 Mar 9.

6.

Factors associated with nonadherence to thiopurines in adolescent and adult patients with inflammatory bowel disease.

Kamperidis N, Goodhand JR, Chowdhury FA, Koodun Y, Direzke NC, Naik S, Sanderson IR, Croft NM, Langmead FL, Irving PM, Rampton DS, Lindsay JO.

J Pediatr Gastroenterol Nutr. 2012 May;54(5):685-9. doi: 10.1097/MPG.0b013e3182475e71.

PMID:
22197942
7.

Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease.

Goodhand JR, Kamperidis N, Rao A, Laskaratos F, McDermott A, Wahed M, Naik S, Croft NM, Lindsay JO, Sanderson IR, Rampton DS.

Inflamm Bowel Dis. 2012 Mar;18(3):513-9. doi: 10.1002/ibd.21740. Epub 2011 May 20.

PMID:
21604328
8.

Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis.

Goodhand JR, Kamperidis N, Nguyen H, Wahed M, Rampton DS.

Aliment Pharmacol Ther. 2011 Mar;33(5):551-8. doi: 10.1111/j.1365-2036.2010.04554.x. Epub 2010 Dec 29.

Supplemental Content

Loading ...
Support Center